Breaking News

WuXi ATU Opens Fourth Manufacturing Facility

Shanghai facility offers integrated development, manufacturing, and testing services for viral vectors and cell therapies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi Advanced Therapies Inc. (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, opened its new process development and commercial manufacturing facility in Lin-gang, Shanghai. WuXi ATU is a Contract, Testing, Development and Manufacturing Organization (CTDMO) headquartered in Philadelphia. The new facility is the company’s fourth manufacturing site worldwide and will supplement sites in the U.S., UK and China with enhanced capacity and services.   The Lin-gang facility offers integrated dev...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters